FLDM Key Statistics, Chart & Performance
The current stock price of FLDM is 3.71 null. In the past month the price increased by 8.8%. In the past year, price decreased by -19.35%.
FLDM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.25 | 229.30B | ||
| DHR | DANAHER CORP | 30.57 | 166.48B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 203.35 | 61.79B | ||
| A | AGILENT TECHNOLOGIES INC | 26.33 | 41.65B | ||
| IQV | IQVIA HOLDINGS INC | 20.88 | 41.36B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.7 | 30.51B | ||
| WAT | WATERS CORP | 31.08 | 23.50B | ||
| ILMN | ILLUMINA INC | 33.55 | 22.35B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.81 | 19.74B | ||
| MEDP | MEDPACE HOLDINGS INC | 42.63 | 17.17B | ||
| TEM | TEMPUS AI INC | N/A | 11.81B | ||
| RVTY | REVVITY INC | 22.81 | 12.39B |
Related stock screener links
About FLDM
Company Profile
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
Company Info
FLUIDIGM CORP
2 Tower Place, Suite 2000
South San Francisco CALIFORNIA 94080 US
CEO: Stephen Christopher Linthwaite
Employees: 615
Phone: 16502666000.0
FLUIDIGM CORP / FLDM FAQ
What does FLUIDIGM CORP do?
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
What is the stock price of FLUIDIGM CORP today?
The current stock price of FLDM is 3.71 null. The price decreased by -7.02% in the last trading session.
What is the dividend status of FLUIDIGM CORP?
FLDM does not pay a dividend.
What is the ChartMill rating of FLUIDIGM CORP stock?
FLDM has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists FLDM stock?
FLDM stock is listed on the Nasdaq exchange.
Should I buy FLDM stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on FLDM.
What is FLUIDIGM CORP worth?
FLUIDIGM CORP (FLDM) has a market capitalization of 285.37M null. This makes FLDM a Micro Cap stock.
FLDM Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to FLDM. When comparing the yearly performance of all stocks, FLDM turns out to be only a medium performer in the overall market: it outperformed 66.04% of all stocks.
FLDM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to FLDM. FLDM may be in some trouble as it scores bad on both profitability and health.
FLDM Financial Highlights
Over the last trailing twelve months FLDM reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS decreased by -6.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -45.36% | ||
| ROA | -21.52% | ||
| ROE | N/A | ||
| Debt/Equity | 0.68 |
FLDM Forecast & Estimates
7 analysts have analysed FLDM and the average price target is 6.12 null. This implies a price increase of 64.96% is expected in the next year compared to the current price of 3.71.
For the next year, analysts expect an EPS growth of -30.77% and a revenue growth -0.48% for FLDM